Home › RegulatoryAGIOS PHARMACEUTICALS, INC. - 10-Q FilingAgios Pharmaceuticals reported Q2 revenue of $5.2B, up 12% YoY and above guidance.SEC EDGAR · July 30, 2026, 13:56 UTCTickers: $AGIO Read the full article at SEC EDGAR